Bank OZK에 대한 매도 수량은 투자자에게 Bank OZK의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Bank OZK (NASDAQ:OZK) 주식, 공매도 수량 보고

Bank OZK

Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit and individual retirement accounts to loan services like real estate, consumer, commercial and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking and other related services.

Bank OZK - 4.625% Series A Non-Cumulative Perpetual Preferred Stock

Rosenblatt analyst Mike Genovese maintains Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) with a Buy and raises the price target from $69 to $110.

News

Price Target

Analyst Ratings

LITE

Rosenblatt Maintains Buy on Lumentum Holdings, Raises Price Target to $110

Rosenblatt analyst Mike Genovese maintains Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Sell and raises the price target from $265 to $320.

ANET

Rosenblatt Maintains Sell on Arista Networks, Raises Price Target to $320

Michigan's cannabis market just keeps getting bigger and bigger. With nearly 2,000 licensed growers and a vast array of dispensary products, consumers can easily get lost <a href="https://www.benzinga.com/general/gaming">in the selection.</a>
From flower to concentrates and edibles, the choices can be overwhelming, leaving consumers wondering what's actually worth their time and money.
See Also:<a href="https://www.benzinga.com/markets/cannabis/24/10/41411086/michigans-cannabis-market-faced-with-oversupply-and-falling-prices"> </a><a href="https://www.benzinga.com/markets/cannabis/24/09/40855760/detroit-minority-cannabis-entrepreneurs-will-get-no-cost-mentorship-and-training-learn-how-to-em">Detroit Minority Cannabis Entrepreneurs Will Get No-Cost Mentorship And Training: Learn How To Empower Your Business In A $3B+ Market</a>
Detroit&#8217;s Metro Times is launching a new weekly column to help navigate this expanding market. The <a href="https://www.metrotimes.com/weed/metro-times-is-searching-for-michigans-best-cannabis-with-new-column-37804840">column</a>, led by Steve Neavling, a seasoned reporter and former medical marijuana grower and caregiver, will provide in-depth reviews of cannabis products sold at Michigan dispensaries.
Neavling wants to help readers find the best products out there, whether they're experienced cannabis users or just starting out.
"Michigan's cannabis market has exploded," Neavling says. "It's surpassed California in sales, and with that comes a flood of new products. My goal is to cut through the noise and give people a solid guide to what's actually worth trying."
<h3 class="wp-block-heading">A Better Way To Shop For Cannabis</h3>
The new column will focus on a range of cannabis products, from flower and concentrates to edibles and topicals. Neavling will provide readers with practical reviews that include factors like flavor, potency and effects.
"THC isn't the only thing that matters," Neavling explains. "Terpenes and cannabinoids are what really shape the high and flavor profile, and people often overlook that."
<h3 class="wp-block-heading">A Resource For All Michigan Consumers</h3>
The first installment of the column drops next Friday and will continue weekly. Each week, it will offer trusted reviews for both seasoned cannabis users and newcomers. The column will also dive into the stories behind Michigan's cannabis cultivators, giving readers a deeper understanding of the products they're choosing.
Neavling is encouraging local cannabis businesses to reach out to <a href="mailto:steve@metrotimes.com">steve@metrotimes.com</a>. if they'd like their products reviewed. He is also and is inviting readers to share recommendations for dispensaries, cultivators and strains they'd like to see featured.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39828818/michigans-cannabis-market-hits-837m-record-whats-driving-the-boom-in-the-midwest">Michigan&#8217;s Cannabis Market Hits $837M Record: What&#8217;s Driving The Boom In The Midwest?</a></li>
</ul>
Cover image made with AI.

Cannabis

Retail Sales

Markets

Media

Looking For The Best Weed In Michigan? This Detroit Newspaper Column Has You Covered

Rosenblatt analyst Mike Genovese maintains Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) with a Buy and raises the price target from $20 to $27.5.

AAOI

Rosenblatt Maintains Buy on Applied Optoelectronics, Raises Price Target to $27.5

Rosenblatt analyst Kevin Cassidy maintains Synaptics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNA#NASDAQ">SYNA</a>) with a Buy and lowers the price target from $130 to $92.

SYNA

Rosenblatt Maintains Buy on Synaptics, Lowers Price Target to $92

Rosenblatt analyst Kevin Cassidy maintains CEVA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEVA#NASDAQ">CEVA</a>) with a Buy and raises the price target from $28 to $35.

CEVA

Rosenblatt Maintains Buy on CEVA, Raises Price Target to $35

Rosenblatt analyst Kevin Cassidy maintains Adeia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADEA#NASDAQ">ADEA</a>) with a Buy and maintains $15 price target.

ADEA

Rosenblatt Maintains Buy on Adeia, Maintains $15 Price Target

Chardan Capital analyst Daniil Gataulin maintains EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) with a Buy and raises the price target from $28 to $33.

EYPT

Chardan Capital Maintains Buy on EyePoint Pharmaceuticals, Raises Price Target to $33

Barrington Research analyst Alexander Paris maintains H&amp;R Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRB#NYSE">HRB</a>) with a Outperform and maintains $70 price target.

Barrington Research Maintains Outperform on H&R Block, Maintains $70 Price Target

Barrington Research analyst Michael Petusky maintains OPKO Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) with a Outperform and maintains $2.25 price target.

Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target

Macquarie analyst Tim Nollen maintains Warner Bros. Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) with a Neutral and raises the price target from $8 to $9.

Macquarie Maintains Neutral on Warner Bros. Discovery, Raises Price Target to $9

BWS Financial analyst Hamed Khorsand maintains Arlo Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) with a Buy and maintains $24 price target.

ARLO

BWS Financial Maintains Buy on Arlo Technologies, Maintains $24 Price Target

Jones Trading analyst Matthew Erdner maintains Real Brokerage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) with a Buy and raises the price target from $6.5 to $7.

REAX

Jones Trading Maintains Buy on Real Brokerage, Raises Price Target to $7

Macquarie analyst Chad Beynon maintains Red Rock Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRR#NASDAQ">RRR</a>) with a Outperform and lowers the price target from $65 to $64.

Macquarie Maintains Outperform on Red Rock Resorts, Lowers Price Target to $64

Macquarie analyst Chad Beynon maintains PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) with a Outperform and raises the price target from $26 to $27.

PENN

Macquarie Maintains Outperform on PENN Entertainment, Raises Price Target to $27

Donald Trump&#8216;s winning the 2024 presidential election is expected to have a negative impact on <a href="https://www.benzinga.com/electric-vehicles">the electric vehicle sector</a>.
Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) could benefit from CEO Elon Musk's close relationship <a href="https://www.benzinga.com/markets/equities/24/11/41832876/elon-musk-shines-in-trump-sweepstakes-a-big-win-for-tesla-dan-ives-thinks-so">with the president-elect</a>. However, the company&#8217;s plan to build a Gigafactory in Mexico could be at stake.
What Happened: Tesla reportedly <a href="https://www.benzinga.com/news/24/02/37305137/tesla-to-kick-off-construction-of-giga-mexico-next-week-nuevo-le-n-governor-confirms">plans to build a gigafactory </a>in Mexico. The facility could produce sub-$30,000 vehicles, Model Y units, batteries and the Cybertruck.
Tesla hasn't confirmed its plans in Mexico. Still, the country's economic minister is asking questions after Trump won on Election Day.
"I'm going to set up a meeting with (Musk) soon so that he tells me exactly what he's thinking and see what we can do so this project moves forward," Mexico Economy Minister Marcelo Ebrard told local radio Thursday, as reported by Reuters.
Original plans for Mexico and other new factory locations may <a href="https://www.benzinga.com/news/23/06/33053957/tesla-gigafactory-mexico-opening-reportedly-delayed-to-early-2025-amid-logistical-hurdles">have been delayed</a> due to the election with Tesla saying in April that it would use its existing factories to build new more affordable vehicles.
Trump's past term in the White House put pressure on foreign-made items shipped to the United States. Prior to the 2024 election win, Trump<a href="https://www.benzinga.com/news/24/10/41397317/trump-defends-his-plans-to-impose-200-tariffs-on-cars-imported-from-china-mexico-hope-union-workers"> has been promising</a> to put a 200% tariff on vehicles imported from China and Mexico.
Tesla did not respond to a request for comment on its plans in Mexico to Benzinga.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110824">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Tesla has several gigafactories around the world that produce and export vehicles to key regions like Europe and Asia.
A gigafactory in Mexico was likely less about exports to other countries and more about bringing vehicles into the U.S.
Investors and analysts will continue monitoring Trump's win and whether it impacts Tesla and the EV sector.
Price Action: Tesla stock closed Friday up 8.1% to $321.22. The company hit a new 52-week high of $328.71 during the trading session. Tesla stock is up 31.5% over the last five days and up 29.3% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41501607/tesla-q3-earnings-highlights-eps-beat-revenue-miss-shares-climb-on-2025-timeline-for-lower-cost-evs">Tesla Q3 Earnings Highlights: EPS Beat, Revenue Miss, Shares Climb On 2025 Timeline For Lower-Cost EVs</a></li>
</ul>
Image: Shutterstock

Politics

Trading Ideas

TSLA

Elon Musk To Ditch Tesla Gigafactory In Mexico After Trump's Win? Economy Minister Wants 'A Meeting'

Macquarie analyst Chad Beynon maintains Golden Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEN#NASDAQ">GDEN</a>) with a Outperform and lowers the price target from $39 to $38.

GDEN

Macquarie Maintains Outperform on Golden Entertainment, Lowers Price Target to $38

Macquarie analyst Tim Nollen maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Underperform and raises the price target from $15 to $16.

Macquarie Maintains Underperform on Unity Software, Raises Price Target to $16

Macquarie analyst Tim Nollen maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Outperform and raises the price target from $130 to $133.

Macquarie Maintains Outperform on Trade Desk, Raises Price Target to $133

Macquarie analyst Tim Nollen maintains Magnite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Outperform and maintains $18 price target.

MGNI

Macquarie Maintains Outperform on Magnite, Maintains $18 Price Target

Bank OZK GAAP EPS of $1.55 beats by $0.01, revenue of $423M in-line

Bank OZK Q3 earnings beat, but net interest income misses the mark

Bank OZK: Solid Q3 Despite Near-Term NIM Pressure

In a report released today, Stephen Scouten from Piper Sandler assigned a Buy rating to Bank OZK (OZK – Research Report), with a price target of $5...

Bank OZK (OZK) Gets a Buy from Piper Sandler

In a report released today, Brandon King from Truist Financial maintained a Hold rating on Bank OZK (OZK – Research Report). The company's shares c...

Bank OZK (OZK) Gets a Hold from Truist Financial

Truist lowered the firm's price target on Bank OZK (OZK) to $46 from $48 and keeps a Hold rating on the shares as part of a broader research note r...

Bank OZK price target lowered to $46 from $48 at Truist

Stephens raised the firm's price target on Bank OZK (OZK) to $51 from $48 and keeps an Equal Weight rating on the shares. In-line Q3 EPS were drive...

Comments

Bank OZK

매도 수량

Bank OZK (NASDAQ:OZK) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌